UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis

PloS one, 2019-08, Vol.14 (8), p.e0220697-e0220697

2019

Link zum Volltext

Verfügbarkeit prüfen

Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial

Journal of gastroenterology and hepatology, 2018-01, Vol.33 (1), p.307-314

2018

Link zum Volltext

Verfügbarkeit prüfen

Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Scientific reports, 2023-11, Vol.13 (1), p.20039-20039, Article 20039

2023

Link zum Volltext

Verfügbarkeit prüfen

Indications for portal pressure measurement in chronic liver disease

Scandinavian journal of gastroenterology, 2012-09, Vol.47 (8-9), p.887-892

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled trial of a postdischarge nursing intervention for patients with decompensated cirrhosis

Hepatology communications, 2024-05, Vol.8 (5)

2024

Link zum Volltext

Verfügbarkeit prüfen

Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study

Frontiers in medicine, 2021-09, Vol.8, p.718896-718896

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial: timing of carvedilol – promoting survivors in cirrhosis

Alimentary pharmacology & therapeutics, 2022-07, Vol.56 (1), p.172-173

2022

Link zum Volltext

Verfügbarkeit prüfen

Postprandial dysfunction in fatty liver disease

Physiological reports, 2023-04, Vol.11 (8), p.e15653-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series

Medicina (Kaunas, Lithuania), 2020-10, Vol.56 (11), p.565

2020

Link zum Volltext

Verfügbarkeit prüfen

Editorial: non‐selective beta blockers—in and out of circulation

Alimentary pharmacology & therapeutics, 2021-03, Vol.53 (5), p.632-633

2021

Link zum Volltext

Verfügbarkeit prüfen

Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices

Cochrane database of systematic reviews, 2018-10, Vol.10 (10), p.CD011510

2018

Link zum Volltext

Verfügbarkeit prüfen

Nurse-driven post-discharge intervention reduces risk of readmission and non-attendance in patients with decompensated liver cirrhosis: a randomized controlled study

Journal of hepatology, 2022-07, Vol.77, p.S64-S65

2022

Link zum Volltext

Verfügbarkeit prüfen

Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double‐blind, placebo‐controlled trial

Hepatology (Baltimore, Md.), 2017-02, Vol.65 (2), p.592-603

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of patients with ascites after PleurX insertion: an observational study

Scandinavian journal of gastroenterology, 2018-03, Vol.53 (3), p.340-344

2018

Link zum Volltext

Verfügbarkeit prüfen

WED-325 - Atorvastatin reduces inflammation markers TNF-α, CD62L and MMP2 in a randomised trial

Journal of hepatology, 2023-06, Vol.78, p.S239-S240

2023

Link zum Volltext

Verfügbarkeit prüfen

Atorvastatin reduces inflammation markers TNF-α, CD62L and MMP2 in a randomised trial

Journal of hepatology, 2023-06, Vol.78, p.S239-S240

2023

Link zum Volltext

Verfügbarkeit prüfen

Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis

Gut, 2011-09, Vol.60 (9), p.1254-1259

2011

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of the soluble urokinase plasminogen activator receptor

PloS one, 2019-08, Vol.14 (8), p.e0220697

2019

Link zum Volltext

Verfügbarkeit prüfen

Gluco-regulatory disturbances in primary biliary cholangitis and non-alcoholic fatty liver disease compared with healthy individuals

Journal of hepatology, 2022-07, Vol.77, p.S331

2022

Link zum Volltext

Verfügbarkeit prüfen

Postprandial dysfunction in metabolic associated fatty liver disease (MAFLD)

Journal of hepatology, 2022-07, Vol.77, p.S154

2022

Link zum Volltext

Verfügbarkeit prüfen

SAT193 - Tunnelated peritoneal catheter versus large volume paracentesis for refractory ascites in cirrhosis: a randomized controlled trial

Journal of hepatology, 2020-08, Vol.73, p.S749-S750

2020

Link zum Volltext

Verfügbarkeit prüfen

Tunnelated peritoneal catheter versus large volume paracentesis for refractory ascites in cirrhosis: a randomized controlled trial

Journal of hepatology, 2020-08, Vol.73, p.S749-S750

2020

Link zum Volltext

Verfügbarkeit prüfen

1338-P: Glucoregulatory Disturbances in Autoimmune Liver Disease and Nonalcoholic Fatty Liver Disease Compared with Healthy Individuals

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Link zum Volltext

Verfügbarkeit prüfen

273-OR: Postprandial Dysfunction in Metabolic Associated Fatty Liver Disease (MAFLD)

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Link zum Volltext

Verfügbarkeit prüfen

The recent reduction in mortality from bleeding oesophageal varices is primarily observed from Days 1 to 5

Liver international, 2010-03, Vol.30 (3), p.455-462

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)
Webseiten
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(28)
Humans
(23)
Gastroenterology & Hepatology
(19)
Female
(17)
Male
(16)
Liver Cirrhosis
(13)
Middle Aged
(13)
Cirrhosis
(11)
Adult
(7)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Aged
(6)
Liver Cirrhosis - Complications
(6)
Liver Diseases
(6)
Portal Hypertension
(6)
Adrenergic Beta-Antagonists - Therapeutic Use
(5)
Biopsy
(5)
Gastroenterology. Liver. Pancreas. Abdomen
(5)
Inflammation
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis

Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial

Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Indications for portal pressure measurement in chronic liver disease

A randomized controlled trial of a postdischarge nursing intervention for patients with decompensated cirrhosis

Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study

Editorial: timing of carvedilol – promoting survivors in cirrhosis

Postprandial dysfunction in fatty liver disease

Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series

Editorial: non‐selective beta blockers—in and out of circulation

Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices

Nurse-driven post-discharge intervention reduces risk of readmission and non-attendance in patients with decompensated liver cirrhosis: a randomized controlled study

Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double‐blind, placebo‐controlled trial

Prognosis of patients with ascites after PleurX insertion: an observational study

WED-325 - Atorvastatin reduces inflammation markers TNF-α, CD62L and MMP2 in a randomised trial

Atorvastatin reduces inflammation markers TNF-α, CD62L and MMP2 in a randomised trial

Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis

Kinetics of the soluble urokinase plasminogen activator receptor

Gluco-regulatory disturbances in primary biliary cholangitis and non-alcoholic fatty liver disease compared with healthy individuals

Postprandial dysfunction in metabolic associated fatty liver disease (MAFLD)

SAT193 - Tunnelated peritoneal catheter versus large volume paracentesis for refractory ascites in cirrhosis: a randomized controlled trial

Tunnelated peritoneal catheter versus large volume paracentesis for refractory ascites in cirrhosis: a randomized controlled trial

1338-P: Glucoregulatory Disturbances in Autoimmune Liver Disease and Nonalcoholic Fatty Liver Disease Compared with Healthy Individuals

273-OR: Postprandial Dysfunction in Metabolic Associated Fatty Liver Disease (MAFLD)

The recent reduction in mortality from bleeding oesophageal varices is primarily observed from Days 1 to 5

Suchergebnisse filtern